Table 2. PFE ameliorates increased PRU... | American Society of Hematology

Table 2.

PFE ameliorates increased PRU caused by SS RBCs in PAF-treated ex vivo mesocecum vasculature

Infusion sequence	PRU						Mean ± SD
Infusion sequence	1	2	3	4	5	6	Mean ± SD
Pre-SS infusion	8.6	7.9	8.1	7.8	8.8	6.9	8.0 ± 0.7
Post-SS infusion	11.0	11.9	20.1	18.4	19.2	11.9	15.4 ± 4.2^*
Oxy Ringer	10.3	10.2	18.1	17.5	13.0	11.3	13.4 ± 3.6^*
Oxy PFE	7.9	8.5	9.9	8.5	8.6	8.8	8.7 ± 0.7

Infusion sequence	PRU						Mean ± SD
Infusion sequence	1	2	3	4	5	6	Mean ± SD
Pre-SS infusion	8.6	7.9	8.1	7.8	8.8	6.9	8.0 ± 0.7
Post-SS infusion	11.0	11.9	20.1	18.4	19.2	11.9	15.4 ± 4.2^*
Oxy Ringer	10.3	10.2	18.1	17.5	13.0	11.3	13.4 ± 3.6^*
Oxy PFE	7.9	8.5	9.9	8.5	8.6	8.8	8.7 ± 0.7

PRU = Pa-Pv (mm Hg)/venous outflow (mL/min)/tissue weight (g).

Abbreviations are explained in Table 1.

Six mesocecum preparations were used (1 to 6).

P < .05 compared with pre-SS and PFE (Newman-Keuls multiple comparisons).